Signacor Therapeutics Limited
Company Profile
Signacor Therapeutics Limited
ni717003•Private Limited With Share Capital
Get Full Access
13/06/2024
1 years
5
4
72110
very low risk
Company Overview
Registration, classification & business activity
Signacor Therapeutics Limited (ni717003) is a private limited with share capital incorporated on 13/06/2024 (1 years old) and registered in belfast, BT71NF. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Financial Overview
£123.6K
£132.2K
£-8.6K
£0
Key Metrics
4
Employees
5
Directors
6
Shareholders
Board of Directors
Filed Documents
Innovate Grants
This company received a grant of £298633.0 for Development Of A Novel Treatment Option For Hypertrophic Cardiomyopathy. The project started on 01/10/2024 and ended on 31/03/2026.
This company received a grant of £408679.0 for Repurposing Epigenetic Therapy For Hypertrophic Cardiomyopathy To Facilitate The Innovation And Growth Of A N.Ireland Cardiac Drug Development Company. The project started on 01/06/2025 and ended on 30/11/2026.
Risk Assessment
very low risk
International Score